Tuberculosis in the time of COVID-19: quality of life and digital innovation

Dina Visca; Simon Tiberi; Emanuele Pontali; Antonio Spanevello; Giovanni Battista Migliori

doi:10.1183/13993003.01998-2020

Tuberculosis in the time of COVID-19: quality of life and digital innovation

Eur Respir J. 2020 Aug 6;56(2):2001998. doi: 10.1183/13993003.01998-2020. Print 2020 Aug.

Authors

Dina Visca^{1

2}, Simon Tiberi^{3

4}, Emanuele Pontali⁵, Antonio Spanevello^{1

2}, Giovanni Battista Migliori⁶

Affiliations

¹ Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
² Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Italy.
³ Dept of Infection, Royal London and Newham University Hospitals, Barts Health NHS Trust, London UK.
⁴ Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London UK.
⁵ Dept of Infectious Diseases, Galliera Hospital, Genoa, Italy.
⁶ Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.

Abstract

COVID-19 affects healthy individuals, patients and healthcare professionals, as well as tuberculosis services. The importance of digital technologies and the impact on quality of life are discussed. https://bit.ly/2U8nA0h

Publication types

Editorial
Comment

MeSH terms

Betacoronavirus
COVID-19
Cohort Studies
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Quality of Life*
SARS-CoV-2
Treatment Outcome
Tuberculosis*